Airsculpt Financial Statements From 2010 to 2025
| AIRS Stock | USD 2.63 0.23 8.04% |
Check Airsculpt Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Airsculpt Technologies' main balance sheet or income statement drivers, such as , as well as many indicators such as . Airsculpt financial statements analysis is a perfect complement when working with Airsculpt Technologies Valuation or Volatility modules.
Airsculpt |
Airsculpt Technologies Company Current Valuation Analysis
Airsculpt Technologies' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Airsculpt Technologies Current Valuation | 261.76 M |
Most of Airsculpt Technologies' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Airsculpt Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Airsculpt Technologies has a Current Valuation of 261.76 M. This is 98.18% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 98.43% higher than that of the company.
Airsculpt Technologies Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Airsculpt Technologies's current stock value. Our valuation model uses many indicators to compare Airsculpt Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Airsculpt Technologies competition to find correlations between indicators driving Airsculpt Technologies's intrinsic value. More Info.Airsculpt Technologies is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Airsculpt Technologies by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Airsculpt Technologies Financial Statements
Airsculpt Technologies shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Airsculpt Technologies investors may analyze each financial statement separately, they are all interrelated. The changes in Airsculpt Technologies' assets and liabilities, for example, are also reflected in the revenues and expenses on on Airsculpt Technologies' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida. Airsculpt Technologies operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 240 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Airsculpt Stock Analysis
When running Airsculpt Technologies' price analysis, check to measure Airsculpt Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Airsculpt Technologies is operating at the current time. Most of Airsculpt Technologies' value examination focuses on studying past and present price action to predict the probability of Airsculpt Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Airsculpt Technologies' price. Additionally, you may evaluate how the addition of Airsculpt Technologies to your portfolios can decrease your overall portfolio volatility.